Back to results
US 2024/0003889 A1Published application
Compositions and Methods for Targeting Cancer Stem Cells
AssigneesSeagen Inc., The General Hospital Corporation
InventorsDavid A. Eavarone, Julie DeSander, Jeffrey Behrens, Bo R. Rueda, Rosemary Foster, Kristen D. Starbuck
Life of this patent
Estimating the term…
Abstract
The present invention provides methods of testing anti-STn antibodies for their ability target cancer stem cells by isolating cancer stem cells from cultures, contacting them with anti-STn antibodies being tested, and measuring resulting cell viability.
Claims2
A method of testing an anti-sialyl Tn antigen (STn) antibody for the ability to target cancer stem cells (CSCs) comprising:
- (a) culturing one or more cell lines,
- (b) isolating one or more sub-fractions, wherein said one or more sub-fractions express at least one CSC marker,
- (c) contacting said one or more sub-fractions with said anti-STn antibody, and
- (d) measuring cell viability in said one or more sub-fractions.
1 more element
2-21. (canceled)
Dependencies are inferred from the claim text.